Search This Site

Search this Site

Expert Panel Consensus – Testosterone Deficiency and Treatment

May 31, 2017

MayoClinicColor_Stacked With all the conflicting reports about testosterone replacement, it is nearly impossible for the average person to sift through all the studies and opinions to make an informed decision. A consensus statement published in the prestigious Mayo Clinic Proceedings, Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions, should help clarify the issues. Among the resolutions unanimously approved by the panel of experts were the following.

  • Testosterone (TD) deficiency is a well-established, clinically significant medical condition that negatively affects male sexuality, reproduction, general health, and quality of life
  • The evidence does not support increased risks of cardiovascular events with T therapy
  • The evidence does not support increased risk of prostate cancer with T therapy
  • The evidence supports a major research initiative to explore possible benefits of T therapy for cardio-metabolic disease, including diabetes

The panel went on to state that no specific testosterone bloo

Posted in Medical News by admin
May 20, 2016

Prostate Cancer Ribbon Testosterone replacement therapy (TRT) in appropriate patients can lead to a reduced risk of heart attack and stroke, lower blood sugar, reduced belly fat, improved bone density, enhanced sexual function and overall vitality to name a few. One of the most persistent and damaging medical myths that has lead to the under utilization of TRT is that testosterone causes, or increases the risk of, prostate cancer. Despite the fact that there has never been a single study supporting this myth, and numerous studies over the last several years debunking it, many physicians still have lingering doubts. These doubts have led to the withholding of TRT from countless patients who would benefit from it. The most recent analysis, No Evidence of TRT Link to Prostate Cancer, not only showed no increased risk of prostate cancer with TRT, but a 50% reduction in the risk of aggressive prostate cancer. And while the researchers emphasize that the results do not prove that TRT has a protective effect on the prostate, the data at least suggests that it does. For Cenegenics patients, especially those on TRT, the result

Posted in Blog, Medical News by admin
April 24, 2016

Menopause“Reluctance to treat menopausal symptoms has derailed and fragmented the clinical care of midlife women, creating a large and unnecessary burden of suffering” according to a March 3rd, 2016 editorial in the New England Journal of Medicine.

With the release of the Women’s Health Initiative study in 2002, many women and doctors alike became fearful of hormones to treat menopause. Little has changed since then in terms of the general perception. This fear has been fueled by the wildly overblow risk of breast cancer and the insinuation that hormones may cause heart problems.

Meanwhile, leading medical societies devoted to the care of postmenopausal women agree that hormone therapy is the most effective treatment for hot flashes, the prevention of osteoporosis, sexual dysfunction and more.

Multiple studies have shown that with the proper patient selection, and with the use of bio-identical hormones, there is actually an overall reduction in mortality, even

Posted in Blog, Medical News by admin
February 9, 2016

medical expertsCardiovascular disease is the number one cause of death in the US, taking more lives than all forms of cancer combined. At Cenegenics, we believe that testosterone replacement in deficient men not only improves quality of life, but can be an integral part of an overall program to reduce your risk of heart attack and stroke.

While the public controversy about the potential dangers of testosterone replacement has subsided somewhat, we are still left with FDA labeling warnings suggesting that testosterone is likely to cause harm to patients with heart disease. This is in contrast to the opinion of the majority of medical experts who disagree with the FDAs position, including the two major endocrinology societies.

There have been numerous articles refuting the studies that started the controversy. The most recent co

Posted in Blog, Medical News by admin
November 17, 2015

Matt LauerRaymond Ishman, MD Director of Medical Quality Assurance, Cenegenics Elite Health President, Cenegenics Philadelphia In a segment of The Today Show which aired on November 12th focusing on men’s health, Matt Lauer demonstrated how getting a body composition scan and blood tests can help establish a baseline for health maintenance. We commend The Today Show for raising awareness for men’s health. At Cenegenics, we have been performing body composition scans and extensive blood work for over 16 years. But we don’t stop there! A major focus of the Cenegenics Elite Health Evaluation is to better identify those at risk for heart disease, the leading cause of death in the US that kills more men and women than all forms of cancer combined. In addition, 50% of those who have a cardiovascular event (heart attack, st

Posted in Blog, Medical News by rishman
September 25, 2015

AACE: No compelling evidence that TRT increases heart attack risk!

The American Association of Clinical Endocrinologists (AACE) has issued a position statement questioning claims that testosterone replacement therapy (TRT) increases the risk of cardiovascular disease among users. The position statement is published in the September 2015 edition of Endocrine Practice…..The AACE believes that even after extensive literature review, there is no compelling evidence to suggest that TRT increases cardiovascular risk. Read more….

Posted in Blog, Medical News by rishman
July 27, 2015

Raymond Ishman, MD Director of Medical Quality Assurance, Cenegenics Elite Health President, Cenegenics Philadelphia   The priorities of the FDA seem more than a little confusing at times. On July 9th, the FDA strengthened a prior warningtestosterone-cypionate regarding non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil), naproxen (Aleve) along with numerous prescription drugs used to treat pain and arthritis. These over the counter and prescription drugs can significantly increase the risk heart attack and stroke. This does not apply to aspirin. The following is a summary of the FDA warning:   

  • IbuprofenNSAIDs increase the risk of heart attack or stroke in patients with or without heart diseaseor risk factors for heart disease.
  •  The ri

Posted in Blog, Medical News by rishman
April 7, 2015

FDA1 Raymond Ishman, MD Director of Medical Quality Assurance, Cenegenics Elite Health President, Cenegenics Philadelphia _______________________________________ In their own words, the “FDA is responsible for protecting the public health by assuring the safety, efficacy and security of human and veterinary drugs…” We put our trust in the FDA to assure the safety of new medications and devices, and to protect us from harm. However, some of their warnings seem to go against their own mission statement. We are frequently given conflicting messages and warnings that are simply not supported by the medical literature. At times, these warnings and even new drug approvals are tainted by personal agendas and conflicts of interest. Take for example, the FDA’s

Posted in Blog, Medical News by rishman
March 4, 2015

Raymond Ishman, M.D.FDA Warning Director of Medical Quality Assurance Cenegenics Elite Health President, Cenegenics Philadelphia At Cenegenics, we frequently employ testosterone therapy, if clinically indicated, as part of our comprehensive wellness programs following a thorough evaluation and blood testing. Yet many have lingering doubts regarding the safety of testosterone therapy in light of recent media hype, lawyer’s ads and even the FDA statement released on March 3rd, read what the medical experts at Harvard and The Mayo Clinic have to say. A 2015 review in the Mayo Clinic Proceedings, titled Testosterone Therapy and Cardiovascular Risk: Advances and Controversies, concluded: “In summary, there is no convincing evidence of increased CV (cardiovascular) risks with T (testosterone) therapy. On the contrary, there appears to be a strong beneficial relationship between normal T and CV health that has not yet been widely appreciated.” You also might want to read

Posted in Blog, Medical News by rishman
February 9, 2015

shapeimage_1 Raymond Ishman, MD Director of Medical Quality Assurance, Cenegenics Elite Health President, Cenegenics Philadelphia It’s no surprise to anyone that as we age, waistlines tend to increase in both men and women. Waist circumference and abdominal fat are major risk factors for heart attack, stroke, diabetes and even Alzheimer’s disease. Many people think that to lose fat, they need to predominantly do aerobic, or cardio type training, generally at the expense of strength training. However, according to a new study by Harvard researchers published in the journal Obesity, this strategy is counterproductive. The study followed over 10,000 men for 12 years. The researchers found that compared to aerobic exercise, weight training led to less of an age related increase in abdominal fat. While not specifically stated in the study, the men who weight trained likely had significantly more muscle to go along with their smaller waistlines. The authors of t

Posted in Blog, Medical News by rishman